title: Role of specific innate immune responses in herpes simplex virus infection of the central nervous system.
abstract: Herpes simplex virus 1 (HSV-1) causes a spectrum of disease, including herpes labialis, herpes keratitis, and herpes encephalitis, which can be lethal. Viral recognition by pattern recognition receptors plays a central role in cytokine production and in the generation of antiviral immunity. The relative contributions of different Toll-like receptors (TLRs) in the innate immune response during central nervous system infection with HSV-1 have not been fully characterized. In this study, we investigate the roles of TLR2, TLR9, UNC93B1, and the type I interferon (IFN) receptor in a murine model of HSV-1 encephalitis. TLR2 is responsible for detrimental inflammatory cytokine production following intracranial infection with HSV-1, and the absence of TLR2 expression leads to increased survival in mice. We prove that inflammatory cytokine production by microglial cells, astrocytes, neutrophils, and monocytes is mediated predominantly by TLR2. We also demonstrate that type I IFNs are absolutely required for survival following intracranial HSV-1 infection, as mice lacking the type I IFN receptor succumb rapidly following infection and have high levels of HSV in the brain. However, the absence of TLR9 does not impact survival, type I IFN levels, or viral replication in the brain following infection. The absence of UNC93B1 leads to a survival disadvantage but does not impact viral replication or type I IFN levels in the brain in HSV-1-infected mice. These results illustrate the complex but important roles that innate immune receptors play in host responses to HSV-1 during infection of the central nervous system.
authors.affiliation: Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA. Jennifer.wang@umassmed.edu
authors.forename: Jennifer P
authors.initials: JP
authors.lastname: Wang
authors.forename: Glennice N
authors.initials: GN
authors.lastname: Bowen
authors.forename: Shenghua
authors.initials: S
authors.lastname: Zhou
authors.forename: Anna
authors.initials: A
authors.lastname: Cerny
authors.forename: An
authors.initials: A
authors.lastname: Zacharia
authors.forename: David M
authors.initials: DM
authors.lastname: Knipe
authors.forename: Robert W
authors.initials: RW
authors.lastname: Finberg
authors.forename: Evelyn A
authors.initials: EA
authors.lastname: Kurt-Jones
mesh_terms: D000818:Animals; D002490:Central Nervous System / Q000276:immunology* / Q000821:virology; D006561:Herpes Simplex / Q000276:immunology* / Q000821:virology; D018259:Herpesvirus 1, Human / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007113:Immunity, Innate; D007370:Interferon Type I / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D053633:Receptor, Interferon alpha-beta / Q000276:immunology; D051193:Toll-Like Receptors / Q000276:immunology
chemical_list: D007370:Interferon Type I; D051193:Toll-Like Receptors; D053633:Receptor, Interferon alpha-beta